M2 EquityBites › January 19, 2011
Linked as:Summary
M2 EQUITYBITES-January 19, 2011-Cellectis' Meganuclease technology prevents viral infection
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
-Cellectis' Meganuclease Technology Prevents Viral Infection
Genome engineering company Cellectis (Alternext: ALCLS), ann...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
New Properties | World Cup Woe for Injury Hit Wallace | i drink i smoke and i don t go to the gym at 6am. golf irishman reveals why he s not your average open champ | Trout Topics | intellispace deploys 10 gigabit metropolitan area network in new york city. | rhk finds fault & service management software a top priority for service providers fault & service mana... | witness systems reports second quarter results. | Accelerated Technology s EDE Benefits From New Features in Microsoft Visual Studio .NET.
